Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period, an investigation by The BMJ ...
Novo Nordisk A/S (NYSE:NVO), the maker of the popular obesity drug Ozempic, has been reprimanded by the U.K.’s Prescription Medicines Code of Practice Authority (PMCPA) for failing to disclose fees ...
Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period, an investigation by The BMJ ...
LONDON, March 16 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab has been suspended from the Association of the British Pharmaceutical Industry (ABPI) for two years over what the ...
Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period, an investigation by The BMJ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback